Abstract:Age-dependent neurodegenerative diseases progressively form aggregates containing both shared components (e.g., TDP-43, phosphorylated tau) and proteins specific to each disease. We investigated whether diverse neuropathies might have additional aggregation-prone proteins in common, discoverable by proteomics. Caenorhabditis elegans expressing unc-54p/Q40::YFP, a model of polyglutamine array diseases such as Huntington's, accrues aggregates in muscle 2-6days posthatch. These foci, isolated on antibody-coupled magnetic beads, were characterized by high-resolution mass spectrometry. Three Q40::YFP-associated proteins were inferred to promote aggregation and cytotoxicity, traits reduced or delayed by their RNA interference knockdown. These RNAi treatments also retarded aggregation/cytotoxicity in Alzheimer's disease models, nematodes with muscle or pan-neuronal A(1-42) expression and behavioral phenotypes. The most abundant aggregated proteins are glutamine/asparagine-rich, favoring hydrophobic interactions with other random-coil domains. A particularly potent modulator of aggregation, CRAM-1/HYPK, contributed <1% of protein aggregate peptides, yet its knockdown reduced Q40::YFP aggregates 7286% (P<10(-6)). In worms expressing A(1-42), knockdown of cram-1 reduced -amyloid 60% (P<0.002) and slowed age-dependent paralysis >30% (P<10(-6)). In wild-type worms, cram-1 knockdown reduced aggregation and extended lifespan, but impaired early reproduction. Protection against seeded aggregates requires proteasome function, implying that normal CRAM-1 levels promote aggregation by interfering with proteasomal degradation of misfolded proteins. Molecular dynamic modeling predicts spontaneous and stable interactions of CRAM-1 (or human orthologs) with ubiquitin, and we verified that CRAM-1 reduces degradation of a tagged-ubiquitin reporter. We propose that CRAM-1 exemplifies a class of primitive chaperones that are initially protective and highly beneficial for early reproduction, but ultimately impair aggregate clearance and limit longevity.

Gelation of cytoplasmic expanded CAG RNA repeats suppresses global protein synthesis

The Gelation of CAG Repeat Expansion RNAs Suppresses Global Protein Translation

Phase Transition and Lysosomal Degradation of Expanded CAG Repeat RNA Suppress Global Protein Synthesis.

Mutant GGGGCC RNA prevents YY1 from binding to Fuzzy promoter which stimulates Wnt/β-catenin pathway in C9ALS/FTD

RNA structure promotes liquid-to-solid phase transition of short RNAs in neuronal dysfunction

Optogenetic Control of GGGGCC Repeat-Containing RNA Phase Transition

RNA phase transitions in repeat expansion disorders

Ribosomal quality control factors inhibit repeat-associated non-AUG translation from GC-rich repeats

Proteins in Aggregates Functionally Impact Multiple Neurodegenerative Disease Models by Forming Proteasome-Blocking Complexes

Nucleolar Stress and Impaired Stress Granule Formation Contribute to C9orf72 RAN Translation-Induced Cytotoxicity

Single-molecule imaging reveals distinct elongation and frameshifting dynamics between frames of expanded RNA repeats in C9ORF72-ALS/FTD

GGC Repeat Expansion in NOTCH2NLC Induces Dysfunction in Ribosome Biogenesis and Translation.

CAG Repeat Expansions Increase N1-Methyladenine to Alter TDP-43 Phase Separation: Lights Up Therapeutic Intervention for Neurodegeneration

RNA recruitment switches the fate of protein condensates from autophagic degradation to accumulation

Ribosome profiling reveals novel regulation of C9ORF72 GGGGCC repeat-containing RNA translation

Nucleobase Clustering Contributes to the Formation and Hollowingof Repeat-Expansion RNA Condensate

m 1 A in CAG repeat RNA binds to TDP-43 and induces neurodegeneration

CRISPR/Cas13d targeting suppresses repeat-associated non-AUG translation of C9orf72 hexanucleotide repeat RNA

CAG repeat expansions create splicing acceptor sites and produce aberrant repeat-containing RNAs

Advances in the Structure of GGGGCC Repeat RNA Sequence and Its Interaction with Small Molecules and Protein Partners

m<SUP>1</SUP>A in CAG repeat RNA binds to TDP-43 and induces neurodegeneration